Heramed Ltd (HMD)

Snapshot

HMD's Principal Activity is the development and manufacture of foetal heart beat monitors and other pregnancy monitoring solutions designed for both home and professional use.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
No dividends paid.

Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Name	Title	Since	Bio
Mr Jonathan Hart	Company Secretary	Mar 2020
Mr Doron Birger	Non-Executive Director	Oct 2018	Mr Doron Birger Non-Executive Director Mr Birger is the former Chairman of Given Imaging (NASDAQ/TASE:GIVN), CEO of Elron electronic industries (Nasdaq/TASE: ELRN) and was a board member, during different periods, in a variety of publicly traded companies. During such period, he was involved in investments, merger and acquisitions, exits, public offerings on NASDAQ and TASE and private equity rounds totalling billions of dollars. Mr Birger currently serves as chairman and board member and consultant to a variety of technology companies, mainly in the medical device field, and conducts many voluntary and public activities. He was also Chairman of Medigus LTD and Insuline. He was also director of MCS MEDICAL, HBL Hadasit and Icecure.
Mr Tal Slonim	Chief Operating Officer,Executive Director	Sep 2018	Mr Tal Slonim Chief Operating Officer,Executive Director Mr Slonim is a qualified engineer and operations manager with over 22 years of experience. He is the co-founder and part-time CEO of Meytar R&D, one of Israel's top R&D services firm. Mr Slonim brings vast knowledge, hands-on capabilities and profound experience in system design of multi-disciplinary, integrated solutions as well as transition to mass manufacturing and production line erection and validation.
Mr David Groberman	Chief Executive Officer,Executive Director	Sep 2018	Mr David Groberman Chief Executive Officer,Executive Director Mr Groberman is a mechanical and bio-medical engineer with over 17 years of experience in developing multi-disciplinary medical technologies across a wide spectrum of the industry. He spent over 8 years as co-founder and Chief Technology Officer at Meytar R&D - one of the leading service provide firms in Israel. During his time with Meytar R&D, he gained, hands-on knowledge and capabilities, leading some of the most challenging projects in the field of multi-disciplinary medical and high-tech devices, ranging from implants to invasive mechanical, electro-mechanical and opto-mechanical instruments, surgical apparatuses and applicators, monitoring, diagnosis and scanning equipment.
Mr David Hinton	Non-Executive Director	Aug 2018	Mr David Hinton Non-Executive Director Mr Hinton has an career in the information and technology sectors and is currently Chief Financial Officer and Company Secretary of Empired Limited, an ASX listed IT and software services provider and prior to that Amcom Telecommunications Ltd. Mr Hinton is also a Director of Auspire - The Australia Day Council of Western Australia.
Dr Ronald (Ron) Peter Weinberger	Non-Executive Chairman,Non-Executive Director	Aug 2018	Dr Ronald (Ron) Peter Weinberger Non-Executive Chairman,Non-Executive Director Dr Weinberger is an experienced technology and business development executive, with a demonstrated history of building significant value at multiple levels in the medical device industry. During his time at Nanosonics, he co-developed their platform technology, launched their breakthrough product Trophon globally and created North American sales team to work alongside GE Healthcare. He also developed the distribution strategy for Europe having partnered with Toshiba Medical Systems (now Canon Medical Systems) and Miele Professional.

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
03/08/20	Ronald (Ron) Weinberger	Buy	+286,000	$0.094	$26,741	On-market trade
20/07/20	David Hinton	Buy	+333,333	$0.09	$30,000	Participation in share purchase plan
28/11/19	Tal Slonim	Issued	1,249,695	$0.185	$231,194	As advised by the company
28/11/19	David Groberman	Issued	1,249,695	$0.185	$231,194	As advised by the company

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Tal Slonim	31/12/2020	N/A	9,245,418	3,651,252	N/A
David Groberman	31/12/2020	N/A	9,245,418	3,651,252	N/A
Ronald (Ron) Weinberger	31/12/2020	486,000	N/A	100,000	N/A
David Hinton	31/12/2020	N/A	358,333	N/A	N/A
Doron Birger	05/10/2018	0	N/A	N/A	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
Altshuler Shaham Trusts Ltd (Holley Pharma Co Ltd A/C)	10,857,385	6.17%
Altor Capital Management Pty Ltd (Altor Alpha Fund A/C)	10,853,467	6.17%
Altshuler Shaham Trusts Ltd (David Groberman A/C)	9,245,418	5.25%
Altshuler Shaham Trusts Ltd (Tal Slonim A/C)	9,245,418	5.25%
Freeman Road Pty Ltd (The Avenue A/C)	6,912,365	3.93%
Citicorp Nominees Pty Limited	5,713,618	3.25%
Etchell Capital Ltd	3,512,500	2.00%
HSBC Custody Nominees (Australia) Limited	3,511,142	2.00%
Altshuler Shaham Trusts Ltd (Michael Nenner A/C)	3,040,774	1.73%
Chris Ntoumenopoulos	3,025,000	1.72%
Mayo Clinic	2,767,691	1.57%
Pula Holdings Pty Ltd (Herath Super Fund A/C)	2,019,000	1.15%
Mrs Amandeep Kaur	1,850,000	1.05%
Bnp Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp)	1,591,586	0.90%
Cardup Syndicate Holdings Pty Ltd (The Cardup Syndicate A/C)	1,533,750	0.87%
Dr Matthew Farrugia	1,394,739	0.79%
Mr Barry John Ashwin & Dr Desiree Silva	1,388,833	0.79%
Sobol Capital Pty Ltd (Boc A/C)	1,305,555	0.74%
S & S Browne Assets Pty Ltd (S & S Browne Investment A/C)	1,225,000	0.70%
J P Morgan Nominees Australia Pty Limited	1,090,949	0.62%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$0.087	30 June
2019	$0.19	28 June

HMD Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.